SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Importance of Doctors’ and Patients’ Preferences in the Prescription Decision
0 references·9 citing·34 second hop
The Importance of Doctors’ and Patients’ Preferences in the Prescription Decision (2000)The Importance of Doctors’ and Patients’ …Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark (2014)Regulation of pharmaceutical …Financial incentives and physicians’ prescription decisions on the choice between brand-name and generic drugs: Evidence from Taiwan (2008)Financial incentives and phys…Substitution, Spending Offsets, and Prescription Drug Benefit Design (2007)Substitution, Spending Offset…Latent class factor models for market segmentation: an application to pharmaceuticals (2007)Latent class factor models fo…What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs? (2004)What Explains the Use of Dire…An empirical model of learning and patient spillovers in new drug entry (2003)An empirical model of learnin…A Simple Model of Pharmaceutical Price Dynamics (2003)A Simple Model of Pharmaceuti…Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. (2002)Exploring generic drug use be…Exploring Generic Drug Use Behavior (2002)Exploring Generic Drug Use Be…Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals (1988)The doctor as double agent: Information asymmetry, health insurance, and medical care (1991)The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization? (2009)Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand (2010)Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians (2015)Advertising as Information (1974)An Exogeneity Test for a Simultaneous Equation Tobit Model with an Application to Labor Supply (1986)Price and Advertising Signals of Product Quality (1986)DIRECT TO CONSUMER ADVERTISING AND PRESCRIPTION CHOICE (2007)What happens in acquisitions? (2012)A Theory of the Allocation of Time (1965)The analysis of household surveys (1997)1. On the Concept of Health Capital and the Demand for Health (2017)Analysis of Qualitative Data (1979)Market Segmentation (2000)Latent Class Models (2004)Hospital Ownership and Public Medical Spending (2000)Physician Agency (2000)The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s (2004)Simulation and the Asymptotics of Optimization Estimators (1989)New Product Diffusion Models in Marketing: A Review and Directions for Research (1991)Decision-Making Under Uncertainty: Capturing Dynamic Brand Choice Processes in Turbulent Consumer Goods Markets (1996)Technology Adoption from Hybrid Corn to Beta-Blockers (2007)Learning Models: An Assessment of Progress, Challenges and New Developments (2011)When Will Workers Follow an Algorithm?: A Field Experiment with a Retail Business (2018)Monopolistic Competition with Outside Goods (1979)A Theory of Rational Addiction (1988)The unpublished manuscript (2018)The Theory of Industrial Organization (1988)Estimating long-run relationships from dynamic heterogeneous panels (1995)The Log of Gravity (2006)What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice (2007)A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance (2010)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2003An empirical model of learning and patient spillovers in new drug entry121 cited
  • 2008Financial incentives and physicians’ prescription decisions on the choice between brand-name and generic drugs: Evidence from Taiwan115 cited
  • 2002Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.109 cited
  • 2002Exploring Generic Drug Use Behavior87 cited
  • 2003A Simple Model of Pharmaceutical Price Dynamics83 cited
  • 2004What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs?79 cited
  • 2007Substitution, Spending Offsets, and Prescription Drug Benefit Design78 cited
  • 2014Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark74 cited
  • 2007Latent class factor models for market segmentation: an application to pharmaceuticals19 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work